Wednesday, August 12th, 2026 - Day 2Wednesday, 12 August 2026 - EST/EDT (Eastern Daylight, GMT-4)

Showing 1 of 1 Streams

Networking Break

8:30am - 9:00am

Networking Breakfast

Showing 3 of 3 Streams

HCP Engagement & Quality

Compliance Monitoring & Risk Management

Data Governance & Reporting

9:00am - 9:15am

Track Chair Kick-Off

Dawn DiPierro - Director, Global Compliance Operations, Insmed

9:15am - 10:00am

Reimagining Speaker Programs — Design High-Value, High-Impact Engagements

Explore how companies are reevaluating speaker program design to balance educational value, compliance expectations and appropriate utilization
Gain perspectives on emerging expectations around documentation, rationale and oversight as scrutiny on these programs continue to increase

Micah Ackerman - Director, Compliance Business Partner, Boehringer Ingelheim

10:00am - 10:45am

Modern HCP Engagement Systems—Implementation, Optimization and What Comes Next

Dawn DiPierro - Director, Global Compliance Operations, Insmed

9:00am - 9:15am

Track Chair Kick-Off

9:15am - 10:00am

Improving Operational Efficiency for Streamlined Reporting and Monitoring

Examine how teams are rethinking processes, workflows and cross-functional alignment to support timely, accurate and resource-efficient
Review strategies for optimizing approval pathways, strengthening communications with business partners and reducing manual network
Explore how different tools and process simplifications can drive consistency while allowing compliance teams to focus on higher-value activities

Shane White - Senior Manager, Compliance, Integra LifeSciences
Sulay Desai - Senior Manager, Compliance Operations, ConvaTec

10:00am - 10:45am

Predictive Analytics for Compliance—Building AI-Driven Monitoring Frameworks

Björn Dupre - Executive Director, Compliance Monitoring and Investigations, Bayer
Ted Lowery - Director, External Disclosure and Data Analytics, GSK

9:00am - 9:15am

Track Chair Kick-Off

9:15am - 10:00am

Data Integrity Under Pressure—Ensuring Accuracy in Aggregate Spend

Examine the leading sources of data discrepancies, including upstream errors, manual edits and inconsistent documentation that directly impacts aggregate spend reporting
Review practical methods for improving data checks, reducing manual corrections and ensuring consistent, accurate data flows from all business directions
Discuss process and governance enhancements that help teams maintain data integrity even during restrictive timelines or high-volume reporting periods

Dan LaVallee - Director-Transparency Reporting, Genmab
Caitlin Oroho - Manager, Global Compliance, PTC Therapeutics, Inc.
Jason DiPietro - Senior Manager, Compliance Data Analytics and Transparency Reporting, Lundbeck US

10:00am - 10:45am

Data Privacy and Access Controls in AI Adoption

Nereida Parks - AI, Regional Privacy and HIPAA Officer, OCA, Olympus Corporation

Showing 1 of 1 Streams

Networking Break

10:45am - 11:15am

Networking & Refreshment Break

Showing 3 of 3 Streams

HCP Engagement & Quality

Compliance Monitoring & Risk Management

Data Governance & Reporting

11:15am - 12:00pm

Fair Market Value 2.0—Practical Approaches for a More Complex Engagement Landscape

Examine how companies are navigating FMV challenges across speaking, consulting and advisory engagements as expectations around justification and documentation continue to increase
Discuss practical approaches to improving rate consistency, strengthening rationale, and supporting audit readiness
Explore how organizations are enhancing FMV processes to balance risk management with operational efficiency

Nicole Aikins - Senior Director, Hcp Engagement Operations, Regeneron

12:00pm - 12:45pm

Smarter KOL Tiering and Identification—Data-Driven Approaches for Today’s Environment

Maria Villanueva - Director, Ethics & Compliance, BioTissue

11:15am - 12:00pm

Expanding Compliance Partnerships – Strengthening Alignment Across Medical, Clinical, and Quality Functions

Explore how compliance is evolving beyond its historic focus on commercial operations, with growing expectations for collaboration across medial affairs, clinical teams, quality and other scientific functions
Review how activities such as scientific engagement, advisory boards and medical-led HCP interactions introduce new oversight, documentation and monitoring needs
Discuss practical ways to build stronger partnerships with non-commercial stakeholders and ensure consistent risk assessment, rationale and escalation processes

Stephanie Macholtz - Vice President, Healthcare Compliance, Organogenesis

12:00pm - 12:45pm

Monitoring Field Interactions—Strengthening Accuracy, Documentation and Issue Detection

Björn Dupre - Executive Director, Compliance Monitoring and Investigations, Bayer
Christian Richardson - Director of Compliance, Celltrion USA

11:15am - 12:00pm

Managing Third-Party Vendors—Oversight, Accountability and Data Quality

Learn the best practices for overseeing third-party vendors involved in data collection, HCP identification, system integration and transparency reporting
Examine approaches for evaluating vendor performance, documenting shared responsibilities and ensuring data accuracy across complex multi-vendor ecosystems
Discuss strategies for strengthening accountability, improving communication pathways and mitigating operational risks, particularly for small and midsize companies with limited internal resources

Tim Ball - Senior Manager, Compliance Reporting and Systems, Ferring Pharmaceuticals
Patrick Thibodeau - Senior Compliance Manager, Kyowa Kirin, Inc.

12:00pm - 12:45pm

HCP Master Data—Reducing Duplicates, Contradictions, and Identification Challenges

Jaime Melendez - Enterprise Data and AI Governance, CSL
Inge Tham - Senior Manager, HCP Transparency Reporting, Edwards Lifesciences

Showing 1 of 1 Streams

Networking Break

12:45pm - 1:45pm

Networking Luncheon

Showing 3 of 3 Streams

HCP Engagement & Quality

Compliance Monitoring & Risk Management

Data Governance & Reporting

1:45pm - 2:30pm

Strategic Spending and Waste Reduction—Ensuring the Right HCP Engagements

Examine how companies are assessing field interactions, meal spend, and speaker utilization to identify low-value engagement patterns
Explore approaches for improving targeting, reallocating resources more effectively and enhancing both educational and strategic value
Gain insights into emerging expectations around spend management as financial pressures increase

Peter Lee - Vice President, Chief Compliance Officer, Kura Oncology

2:30pm - 3:15pm

Partnering with Professional Societies and Medical Associations—Expanding Reach While Maintaining Compliance

Examine how compliance requirements, conflict-of-interest safeguards and access restrictions influence how companies engage specific HCP audiences
Explore how professional societies, clinical associations, academic groups and other external organizations serve as trusted channels for collaboration
Review strategies for building compliant, well-documented partnerships that strengthen targeting enhance engagement quality, and reach specialized or hard-to-access HCP segments

1:45pm - 2:30pm

Issue Management and Internal Controls—Building a More Proactive Risk Frameworks

Explore how organizations strengthen issue identification, escalation, and remediation processes to support more proactive and transparent risk management
Review approaches for developing internal controls, particularly for small and midsize biopharma teams with limited resources and infrastructure

Eleni Farrell - US Compliance Business Partner, Insmed

2:30pm - 3:15pm

Risk Signals and Early Indicators—Detecting Audit Issues Before They Emerge

Examine key patterns and data signals that often precede audit findings, errors, or compliance concerns across transparency and HCP engagement activities
Explore practical early-warning tools and monitoring approaches that are adaptable for both large organizations and smaller biopharma teams without advanced systems
Discuss how timely detection, targeted escalation and structured review cycles can strengthen audit readiness and reduce downstream risks

Eric Jen - Director of Compliance, Cytokinetics Inc

1:45pm - 2:30pm

System Integrations and M&A Complexity—Managing Data During Organizational Change

Examine how mergers, acquisitions, and system consolidations affect data consistency and transparency reporting readiness
Review strategies for managing integrations finance, commercial operations, medical affairs and IT to reduce disruptions and reporting gaps
Discuss practical steps for maintaining data integrity during transitions, including validation processes and cross-functional coordination

Brenda Crabtree - Senior Director, Commercial Legal & Compliance, Kura Oncology

2:30pm - 3:15pm

[Case Study] Building a Resilient Aggregate Spend & HCP Engagement Data Ecosystem

Explore how Corcept Therapeutics built a high resilience, end to end aggregate spend and HCP engagement data ecosystem designed to withstand organizational changes, new data flows, and evolving transparency requirements
Hear firsthand how the system captures speaker programs, HCP interactions, contracting data, expenses, touchpoints and real time changes with minimal disruption and exceptionally strong data integrity
Learn how the team designed future proof workflows that can scale with business growth, absorb process changes and maintain reporting accuracy even during periods of restructuring or evolving operational models

Ben McKinley - Senior Manager, Aggregate Spend, Corcept Therapeutics Inc

Showing 1 of 1 Streams

Networking Break

3:15pm - 3:45pm

Networking & Refreshment Break

Showing 1 of 1 Streams

General Session

3:45pm - 4:30pm

AI and Automation in Reporting—Practical Use Cases for Efficiency and Accuracy

Explore how companies are applying AI and automation to streamline data processing, reduce manual workload, improve reporting timelines, and identify anomalies earlier in the transparency lifecycle.
Examine real‑world examples of automated workflows, machine learning models, and anomaly‑detection tools that enhance data quality, strengthen audit readiness, and improve downstream reporting accuracy.
Discuss governance and oversight considerations, including data privacy safeguards, model transparency, role‑based access, and responsible AI adoption to ensure automated tools support, not replace critical compliance decision‑making

Charles de Gaspe Beaubien - Founder and Chief Commercial Officer, Groupize

4:30pm - 5:15pm

The Future of Integrated Transparency – Aligning Compliance, Data, and Engagement in a Converging Landscape

Explore how transparency, HCP engagement, data governance, and monitoring functions are converging and what this means for future organizational structures, ownership models, and cross‑functional collaboration
Examine emerging expectations from regulators, business partners, and external stakeholders, and how companies are rethinking processes, systems, and decision frameworks to prepare for the next phase of transparency evolution
Discuss the long‑term capabilities organizations must build, including data literacy, agile workflows, and AI‑ready governance, to stay ahead in an increasingly complex and integrated compliance environment

Showing 1 of 1 Streams

Networking Break

5:15pm - 6:15pm

Close of Day Two and Networking Reception